Evidence map›Paper›PMID 34575111›Full record

ReviewLife (Basel, Switzerland)2021

Features of the Skin Microbiota in Common Inflammatory Skin Diseases.

Iva Ferček, Liborija Lugović-Mihić, Arjana Tambić-Andrašević, Diana Ćesić, Ana Gverić Grginić, Iva Bešlić, Marinka Mravak-Stipetić, Iva Mihatov-Štefanović, Ana-Marija Buntić, Rok Čivljak

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Novel drug delivery systems in topical treatment of atopic dermatitis.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Whole genome sequencing distinguishes skin colonizing from infection-associatedFrontiers in cellular and infection microbiology · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Iva FerčekDepartment of Dermatovenereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Liborija Lugović-MihićDepartment of Dermatovenereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.ORCID 0000-0001-7494-5742
Arjana Tambić-AndraševićSchool of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Diana ĆesićDepartment of Dermatovenereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Ana Gverić GrginićDepartment of Clinical Microbiology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Iva BešlićDepartment of Dermatovenereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Marinka Mravak-StipetićSchool of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Iva Mihatov-ŠtefanovićSchool of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Ana-Marija BuntićDepartment of Pediatrics, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Rok ČivljakDepartment for Respiratory Infections, University Hospital for Infectious Diseases "Dr. Fran Mihaljević", 10000 Zagreb, Croatia.ORCID 0000-0001-8766-7438
University Hospital Centre Zagreb · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many relatively common chronic inflammatory skin diseases manifest on the face (seborrheic dermatitis, rosacea, acne, perioral/periorificial dermatitis, periocular dermatitis, etc.), thereby significantly impairing patient appearance and quality of life. Given the yet unexplained pathogenesis and numerous factors involved, these diseases often present therapeutic challenges. The term "microbiome" comprises the totality of microorganisms (microbiota), their genomes, and environmental factors in a particular environment. Changes in human skin microbiota composition and/or functionality are believed to trigger immune dysregulation, and consequently an inflammatory response, thereby playing a potentially significant role in the clinical manifestations and treatment of these diseases. Although cultivation methods have traditionally been used in studies of bacterial microbiome species, a large number of bacterial strains cannot be grown in the laboratory. Since standard culture-dependent methods detect fewer than 1% of all bacterial species, a metagenomic approach could be used to detect bacteria that cannot be cultivated. The skin microbiome exhibits spatial distribution associated with the microenvironment (sebaceous, moist, and dry areas). However, although disturbance of the skin microbiome can lead to a number of pathological conditions and diseases, it is still not clear whether skin diseases result from change in the microbiome or cause such a change. Thus far, the skin microbiome has been studied in atopic dermatitis, seborrheic dermatitis, psoriasis, acne, and rosacea. Studies on the possible association between changes in the microbiome and their association with skin diseases have improved the understanding of disease development, diagnostics, and therapeutics. The identification of the bacterial markers associated with particular inflammatory skin diseases would significantly accelerate the diagnostics and reduce treatment costs. Microbiota research and determination could facilitate the identification of potential causes of skin diseases that cannot be detected by simpler methods, thereby contributing to the design and development of more effective therapies.

Indexed as

acne vulgarisatopic dermatitisfacial skininflammatory skin diseasesperiocular dermatitisperioral dermatitisperiorificial dermatitispsoriasisrosaceaseborrheic dermatitisskin diseasesskin microbiota

Identifiers

PMID34575111
PMCPMC8468136
OpenAlexW3199605604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.